Pharmaceutical companies including Baxter, Biogen Idec and GlaxoSmithKline, through its SR One subsidiary, all backed the round, which also included funds from True Norths' parent company iPierian.

The Chinese company has invested $34m in Cardio3 in addition to forming a joint venture to commercialise a heart failure indicator.

Legend Capital has invested in a $32.6m round raised by Axonics Modulation Technologies, which is developing technology to treat chronic pain.

Google Capital was among the investors in a Tiger Global-led round for Freshdesk, which brought the software-as-a-service provider's total funding to $44m.

GE and Mayo Clinic were among the investors in the round, which Chrono intends to use to the capital to complete its digital aid for stopping smoking.

Digital marketing and data management firm Krux has followed an IDG-backed $11m series B round in 2011 with a $35m round also backed by SAP and Time Warner.

Celgene secured the money two months after raising $100m from the Kuwait Investment Authority and additional funding from Blackberry.

Applied Materials' corporate venturing unit has announced that it was among the investors in the synthesised gene producer's $26m round in May.

The menstruation tracking app and social network has now raised $45m in total, with Bertelsmann one of the investors.

The file sharing technology developer has secured $20m in a series B round in which IDG joined its previous backers Northern Light and Innovation Works.